New hope for Tough-to-Treat leukemia: early trial tests Triple-Drug attack
Disease control
Recruiting now
This early-stage trial is testing a new combination of drugs for adults whose acute myeloid leukemia (AML) has returned or not responded to prior treatment. The main goals are to find safe doses and see if adding a new drug called imetelstat to standard treatments helps control t…
Phase: PHASE1 • Sponsor: Douglas Tremblay • Aim: Disease control
Last updated Apr 02, 2026 05:11 UTC